Treatment of Uremic Pruritus by Olive-omega 3 Ointment
NCT01447693 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2011-10-06
Summary
Background.
Uremic pruritus is still a common phenomenon in patients with end-stage renal failure. It is regarded as one of the most bothersome symptoms in patients on chronic dialysis.
The pathogenesis of uremic itch remains unclear. Several theories have been proposed like dryness of the skin, imbalance in divalent ions, peripheral neuropathy and others.
Many treatment modalities have been tried to reduce uremic pruritus, however , the majority of them produced only temporary improvement. Therefore , every new therapeutic option for uremic pruritus is desirable.
This study will undertaken to evaluate the efficacy of a cream which included olive oil and omega-3 fatty acids.
Olive Omega-3 is an efficient product that soothes itchiness of cracked and very dry skin.
The product is unique and based on patented technology developed by the Technion Research and Development Foundation in Haifa.
Olive Omega-3 is an ointment composed of all natural ingredients. The main active ingredients are extra virgin olive oil , fish oil and vitamin C. The oils provides the skin with fatty acids that are vital for its proper functioning and help in the skin recovery. Sugar cane extract improves the skin's flexibility by removing dead cells and enhancing water retention in the upper layer of the skin.
When applied on clean skin , the product is quickly absorbed , producing a sensation of relief within a short time period. Treatment can be repeated as often as required with no limitations and its use is not contraindicative of any other medical treatment.
Patients and Methods.
About 20 patients on chronic hemodialysis suffering from uremic pruritus will be include in the study.
All patients will undergo dermatologic examination. All patients will be score by intensity of itching according to 3-point scale , as follows:
1. \- patches of fine , powdery scales
2. \- moderate scaling with beginning cracks
3. \- intense scaling , moderate cracks The patients all applied Olive Omega-3 ointment for 50% of body and Vaseline ointment for the second one. The treatment will repeated twice daily for two weeks.
At the end of 2 weeks application global tolerance will evaluate using the following 3-point scale:
1. very good
2. good
3. poor
At the same time global agreement of the patients will evaluate according to the following scale :
1. \- very satisfactory
2. \- satisfactory 3- poorly satisfactory.
Statistical analysis will be performed by use of Wilcoxon test .
Conditions
- Uremic Pruritus
Interventions
- PROCEDURE
-
application of ointment (olive-omega 3 ointment)
Sponsors & Collaborators
-
Assaf-Harofeh Medical Center
lead OTHER_GOV
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
The Treatment Effect of Chinese Medicine Formula on Uremic Pruritus
NCT04650750 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Cool Baby Oil for Pruritus and Sleep Quality Among Uremic Patients
NCT05555524 ·Status: COMPLETED ·Phase: NA
-
An Observational Study of Pruritus Amongst Hemodialysis Patients
NCT00715260 ·Status: UNKNOWN
-
Effect of Olive Oil on Erythrocyte Membrane Fatty Acid Contents in Hemodialysis Patients
NCT02993380 ·Status: COMPLETED ·Phase: NA
-
Uremic Pruritus, Cytokines and Polymethylmethacrylate Artificial Kidney
NCT00442819 ·Status: COMPLETED ·Phase: PHASE4
-
Acupuncture for Pain Management of Hemodialysis Patients
NCT01102816 ·Status: TERMINATED ·Phase: NA
-
A Trial on the Efficacy and Safety of Virgin Coconut Oil Compared to Mineral Oil in the Treatment of Uremic Xerosis
NCT01445431 ·Status: COMPLETED ·Phase: PHASE3
-
DIalysis Symptom COntrol-Pruritus Outcome Trial
NCT05180968 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Hemodialysis on Exhaled Volatile Organic Compounds in End Stage Renal Disease
NCT01684228 ·Status: COMPLETED
-
Low-level Laser Therapy in Chronic Kidney Disease
NCT02944760 ·Status: UNKNOWN ·Phase: NA
-
Sertraline Effect in Uremic Pruritis
NCT05341843 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Factors of Thrombocytopenia In Chronic Kidney Disease And Hemodialysis Patients In Assiut University Hospitals
NCT06163144 ·Status: NOT_YET_RECRUITING
-
Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients
NCT00420290 ·Status: COMPLETED ·Phase: NA
-
The Effect and Safety of Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia Patients
NCT02747979 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Reduction of Oxalate and Inflammation by Hemodiafiltration vs. Hemodialysis
NCT02684656 ·Status: COMPLETED ·Phase: NA
-
Effect of Kidney Replacement Therapy with Polymethylmethacrylate Membranes on Pruritus-related Quality of Life in Patients Receiving Maintenance Haemodialysis
NCT06671535 ·Status: RECRUITING ·Phase: NA
-
The Effectiveness and the Safety of Acupuncture for Symptomatic Care of Hemodialysis Patients: A Case-series
NCT00883831 ·Status: COMPLETED ·Phase: NA
-
Acid-Base Composition With Use of hemoDialysates
NCT02334267 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Fatigue in Hemodialysis Patients
NCT01846754 ·Status: COMPLETED
-
Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis
NCT02338635 ·Status: UNKNOWN ·Phase: PHASE4
-
Factors Affecting Dialysis Associated Fatigue
NCT06123806 ·Status: NOT_YET_RECRUITING
-
Hemodiafiltration With Endogenous Reinfusion on Uremic Toxins Clearance of Maintenance Hemodialysis Patients
NCT06002529 ·Status: UNKNOWN ·Phase: NA
-
Relations Between Residual Renal Function and Oxidative and Carbonyl Stress in Peritoneal Dialysis Patients
NCT00692068 ·Status: COMPLETED
-
Impact of Dialysis on Sexuality.
NCT07332949 ·Status: RECRUITING
-
Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis
NCT01353638 ·Status: TERMINATED ·Phase: PHASE1/PHASE2